AC
ELOX

Armistice Capital’s Eloxx Pharmaceuticals, Inc. Common Stock ELOX Stock Holding History

Armistice Capital’s Portfolio ELOX Stock Details ELOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-275,000
Closed -$1.32M – 374
2023
Q3 		$1.32M Buy
+275,000
New +$1.54M 0.02% 140

Other funds holding ELOX

MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
AS
Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return

Armistice Capital's ELOX Position: Q4 2023 in Review

Armistice Capital sold out of Eloxx Pharmaceuticals, Inc. Common Stock (ELOX) in Q4 2023, closing a stake of 275,000 shares — an estimated $1.32M sold.

Armistice Capital first reported a position in ELOX in Q3 2023 and held it in 1 quarter. The position peaked at $1.32M in Q3 2023. 4 funds tracked by Wall St. Rank hold ELOX as of Q4 2023.

  • Armistice Capital reported no remaining Eloxx Pharmaceuticals, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Armistice Capital sold 275,000 Eloxx Pharmaceuticals, Inc. Common Stock shares in Q4 2023, an estimated $1.32M.
  • Armistice Capital first reported a position in Eloxx Pharmaceuticals, Inc. Common Stock in Q3 2023 and held it in 1 quarter.
  • Armistice Capital's Eloxx Pharmaceuticals, Inc. Common Stock position peaked at $1.32M in Q3 2023.
  • 4 funds tracked by Wall St. Rank held Eloxx Pharmaceuticals, Inc. Common Stock as of Q4 2023.

Based on Armistice Capital's 13F filing for Q4 2023, filed 13 Feb 2024.